Abnormal erythrocyte choline and influx in Alzheimer's disease
Bruce L. Miller(University of California, San Francisco), D. Frank Benson(Baycrest Hospital), Stephen Read(UNSW Sydney), Jeffrey L. Cummings(University of California, Los Angeles), Kathleen M. Rice(University of California, Los Angeles), Donald J. Jenden(University of California, Los Angeles)
Cited by 31
Related Papers
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
|Nature Genetics|2011|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k
Alzheimer's disease
|Nature Reviews Disease Primers|2015|1.8k
Positron Emission Tomography in Evaluation of Dementia
|JAMA|2001|952
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
|Alzheimer s Research & Therapy|2021|818